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Sphingolipids such as ceramide and sphingosine are
abundantly present in the stratum corneum of epidermis.
In atopic stratum corneum, sphingosylphosphorylcholine
(SPC) is present in association with a reduction in the
amount of ceramides. We have previously shown that
the cellular kinetics of T cells are affected by exogenous
addition of sphingosine and synthetic ceramides, raising
the possibility that sphingolipids diffusing from the
stratum corneum modulate skin-infiltrating T cells. By
using two natural ceramides and murine T cells, this study
further clarified the conditions under which exogenous
ceramides enhance the proliferation of T cells. KLH-
specific T cell clones 28–4 and 24–2 proliferated in
response to natural ceramides when cultured for 44–48 h
in the presence of concanavalin A at 1 mg per ml.
Sphingomyelin turnover is a novel pathway for transmem-brane signal transduction in which sphingolipids participatein cell growth, differentiation, apoptosis, and immune recog-nition and responsiveness (Ballou, 1992; Hannun, 1994;Kolesnick and Fuks, 1995; Pushkareva et al, 1995). Ceram-
ides, the N-acylated form of sphingolipids, are produced by hydrolysis
of sphingomyelin (Kim et al, 1991; Pushkareva et al, 1995; Kolesnick
and Fuks, 1995). They function as an important mediator, typically in
signaling by tumor necrosis factor α (TNFα) (Kim et al, 1991; Dressler
et al, 1992; Bettaieb et al, 1996), which mediates proliferation, functional
activation, and apoptotic cell death depending on the target cell type
(Kolesnick and Fuks, 1995). Synthetic, cell-permeable ceramides are
widely used for analysis of the sphingomyelin pathway (Kim et al,
1991; Dressler et al, 1992). More recently, exogenous addition of
natural ceramides, which exert biologic effects similar to synthetic
ceramides, has provided more direct evidence for the function of
sphingolipid as a second messenger (Hartfield et al, 1997; Ji et al, 1995;
Geilen et al, 1996). On the other hand, the mitogenic activity of the
N-deacyl derivatives of sphingolipids such as sphingosine, sphingosine-
1-phosphate, and sphingosylphosphorylcholine (SPC) has been reported
in various systems (Spiegel and Milstien, 1995).
Ceramide and sphingosine are also well known as intercellular lipids
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Elongation of culture periods adversely inhibited the
T cell proliferation, suggesting the existence of an optimal
exposure time. Augmentation of DNA synthesis by nat-
ural ceramides was more pronounced in tumor necrosis
factor a (TNFa)-sensitive 28–4 cells than in less sensitive
24–2 cells, and TNFa-induced proliferation of 28–4 cells
was suppressed by the concomitant addition of natural
ceramides. Similar to ceramides, SPC augmented the
proliferation of resting spleen cells. Our study suggests
that ceramide modulation of T cell proliferation depends
on the TNFa sensitivity and activation level of T cells
and that SPC also has a mitogenic potential for T cells.
Key words: DNA synthesis/T cell/sphingolipid/tumor necrosis
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involved in the water-holding function of the stratum corneum of
epidermis (Imokawa et al, 1991). The presence of a large amount of
sphingolipids in the stratum corneum raises the possibility that when
destroyed by mechanical or inflammatory stimuli, the stratum corneum
releases these lipids, which modulate cellular kinetics of keratinocytes
and/or skin-infiltrating lymphocytes. Therefore, it is important in not
only basic but also dermatologic fields to investigate the effects of
exposure to sphingolipids on cellular kinetics of these skin-constituent
cells. In this concept, keratinocyte-differentiating and -proliferating
potentials of sphingolipids imply the involvement of these lipids in
some skin conditions (Wakita et al, 1994). Furthermore, a recent
finding that SPC is abnormally generated in the stratum corneum of
patients with atopic dermatitis (Murata et al, 1996) indicates an etiologic
role for SPC in certain skin disorders.
In addition to the phosphatidylinositol pathway (June et al, 1990),
sphingomyelin turnover participates profoundly in biologic events of
certain types of T cells (Boucher et al, 1995; Chan and Ochi, 1995;
Geley et al, 1997). It has recently been shown that ceramides play a
crucial role in several T cell processes such as the CD28-mediated
intracellular signaling pathway (Boucher et al, 1995; Chan and Ochi,
1995) and apoptosis (Geley et al, 1997). Thus, ceramides are capable
of inducing two mutually exclusive cellular functions, proliferation and
death (Kolesnick and Fuks, 1995). Reflecting this concept, the effect
of exogenous addition of ceramide on the proliferation of T cells
remains equivocal. Exposure to synthetic, cell-permeable ceramides
has been reported to suppress DNA synthesis of human T cells
stimulated with either interleukin (IL)-2 or phorbol ester plus iono-
mycin (Borchardt et al, 1994) and that of murine T cells treated with
phytohemagglutinin or concanavalin A (Con A) (Felding-Habermann
et al, 1990). This inhibitory effect of ceramides on T cell proliferation
is confirmed by an inverse relationship between cellular concentrations
of ceramides and proliferative capacity in T cells (Borchardt et al,
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1994). In contrast, another group of investigators has shown that
addition of synthetic ceramide to lymphocyte cultures significantly
enhances mitogen-induced proliferation (Jolly et al, 1996).
We have compared synthetic ceramides with sphingosine in terms
of their effects on the cellular kinetics of T cells. Whereas sphingosine
inhibited DNA synthesis with retardation of G1 to S phase progression
in certain T cells, synthetic ceramide induced modest proliferation of
splenocytes and lymph node cells (LNC) unless stimulated with a
mitogen, cytokine, or antigen (Tokura et al, 1996). The exogenous
addition of a short chain ceramide N-acetylsphingosine (C2) at 10 µM
augmented DNA synthesis of nonstimulated spleen cells and immune
LNC by 30%–58%. Such enhancement was not found in N-hexanoyl-
sphingosine (C6) or N-octanoylsphingosine (C8), as these two ceram-
ides at 10 µM inhibited the DNA synthesis of immune LNC. In
contrast, C2 did not enhance proliferative responses of any types of
lymphocytes when they were stimulated with a mitogen, a cytokine,
or antigen/accessory cells (Tokura et al, 1996). These results obtained
with synthetic ceramides and mixed populations of lymphocytes
suggested that the action of ceramides on T cell proliferation depends
on the target cell type, the cellular activation state, and the type
of ceramide.
To clarify this issue, we cultured T cell clones with natural ceramides
under various conditions. This study shows that exogenous natural
ceramides augment DNA synthesis most pronouncedly in T cells that
are TNFα-sensitive, not fully activated, and cultured for 2 d. In
addition, we also provide evidence for the T cell-proliferative capacity
of SPC that is increased in atopic dermatitis instead of ceramides.
MATERIALS AND METHODS
Animals Female BALB/C mice (Japan SLC, Hamamatsu, Japan), 8–10-wk-
old, were used in all experiments.
Ceramides and SPC The following two natural ceramides from bovine
brain with 99% purity were purchased from Sigma (St. Louis, MO): type III
(CIII) prepared by the action of phospholipase C on sphingomyelin (Morrison,
1969) and type IV (CIV) from cerebrosides (Carter and Gaver, 1967). CIII is
a nonhydroxy form and CIV is hydroxy fatty acid ceramide, and thus the
difference between them is the absence or presence of a hydroxy residue at the
α site of the structural backbone. These ceramides were dispersed into a solvent
mixture of ethanol and dodecane (Ji et al, 1995). SPC was purchased from
Sigma and dissolved in absolute ethanol (100 mM). A short chain ceramide,
C2, was prepared by N-acylation of D-erythro-sphingosine using anhydrous
acetic acid, hexanoylchloride, and octanoylchloride (Aldrich Chemicals, Mil-
waukee, WI) (molar ratio, 1:10) as reported previously (Gaver and Sweeley,
1966). After removing residuals on a DEAE-Sephadex (Sigma) column, the
eluate was incubated in 1N NaOH to dissect esterified bonds. The products
were purified by preparative thin-layer chromatography and purity of over 95%
was verified by high-performance liquid chromatography analysis (Wakita
et al, 1992).
Ceramides and SPC were conjugated with fatty acid-free bovine serum
albumin (BSA; Boehringer Mannheim, Indianapolis, IN) (Merrill et al, 1989).
Briefly, an aliquot of ceramide was added to 2 mM fatty acid-free BSA dissolved
in phosphate-buffered saline (PBS, pH 7.4) to form stock solutions of ceramide-
albumin complex at a molar ratio of 1:1. The same concentration of BSA
without ceramide was used as a control.
Culture medium RPMI-1640 (Gibco Laboratories, Grand Island, NY) was
supplemented with 10% heat-inactivated fetal calf serum, 2 mM L-glutamine,
5 3 105 M 2-mercaptoethanol, 10–5 M sodium pyruvate, 25 mM HEPES, 1%
nonessential amino acids (Gibco), 100 units penicillin per ml, and 100 µg
streptomycin per ml.
Keyhole limpet hemocyanin (KLH)-specific T cell clones 28–4 and
24–2 Two KLH 1 I-Ak-specific CD41 T cell clones, 28–4 and 24–2
(Nakayama et al, 1988, 1989), were kindly provided by Dr Y. Asano, Department
of Immunology, Faculty of Medicine, Ehime University. These cell clones were
used 3 wk after feeding with KLH (Sigma; final concentration, 10 µg per ml),
feeder cells, and Con A-stimulated rat spleen cell supernatants. To test the effect
of addition of ceramides on cell proliferation, these cell clones (4 3 104 cells
per well) were cultured with ceramide in the presence of 1 µg Con A per ml,
because the addition of Con A at this concentration allowed us to detect T cell
stimulatory potencies of ceramides as described in detail below.
LNC primed by contact sensitization with trinitrophenyl (TNP) (TNP-
LNC) Mice were sensitized with picryl chloride (2,4,6-trinitrochlorobenzene;
Tokyo Kasei, Tokyo, Japan) by painting 50 µl of 5% picryl chloride in
ethanol:acetone (3:1) onto the clipped abdomens. Inguinal and axillary lymph
node cells were taken 7 d after sensitization. Langerhans cell-enriched epidermal
cells were prepared and used as antigen-presenting cells as described previously
(Tokura et al, 1994). The Langerhans cell-enriched cell population contained
approximately 15% I-A1 cells, representing Langerhans cells. TNP-LNC
(3 3 105 cells per well) were stimulated with TNP-modified Langerhans cell-
enriched epidermal cells (105 cells per well). For TNP-modification, Langerhans
cell-enriched epidermal cells (107 per ml) in PBS were incubated with an equal
volume of 10 mM 2,4,6-trinitrobenzene sulfonic acid (Tokyo Kasei) in PBS at
room temperature for 30 min (Greene et al, 1978).
Assay for T cell responses and calculation of percentage enhancement
by ceramides The 28–4, 24–2, and TNP-LNC were cultured in triplicate
in the presence or absence of relevant stimulants in 96 well microtiter plates
(Corning Glass Works, Corning, NY) at 37°C under 5% CO2 in air. Ceramides
and BSA as a control were added at the beginning of culture. Methyl-tritiated
thymidine ([3H]TdR) (Amersham Intl., Arlington, IL; 1 µCi per well) was
added to the culture 14–16 h before harvest. The cells were harvested on glass
fiber filters using a cell harvester (Cambridge Technologies, Watertown, MA)
and their radiouptake was measured in a scintillation counter.
The percentage augmentation of the response, when stimulants, i.e., TNFα,
IL-1β, and/or Con A were added, was calculated as follows: (cpm of ceramide
addition group – cpm of BSA addition group)/(cpm of BSA addition group –
cpm of nonstimulated group)3100. When a stimulant was not added, the
percentage augmentation represented (cpm of ceramide addition group – cpm
of BSA addition group)/(cpm of BSA addition group).
TNFα and IL-1 induce sphingomyelin hydrolysis and thus are agonists of
sphingomyelin turnover (Kim et al, 1991; Dressler et al, 1992; Mathias et al,
1993; Bettaieb et al, 1996). Moreover, TNFα synergizes IL-1 in stimulation of
certain T cell populations (Tokura et al, 1994; Solari et al, 1990). To examine
the synergistic effect of IL-1β and TNFα, 28–4, 24–2 (4 3 104 cells per well)
and murine thymocytes (106 cells per well) were cultured for 48 h with varying
doses of murine recombinant IL-1β and/or murine recombinant TNFα
(Genzyme, Boston, MA) in the presence of Con A (1 µg per ml). This
experimental protocol was virtually the same as that for evaluation of augmentat-
ive effects of IL-1 and TNFα on lectin-stimulated proliferation of thymocytes
(Ranges et al, 1988) and T cell clones (Tokura et al, 1994). [3H]TdR
incorporation was assessed as described above.
Assay for responses of splenocytes, thymocytes, and TNP-LNC to
SPC Spleen and thymus cell suspensions were obtained from mice and
erythrocytes in splenocyte suspensions were lyzed in 0.83% ammonium chloride.
Splenocytes (3 3 105 cells per well), thymocytes (106 cells per well), and TNP-
LNC (3 3 105 cells per well) were cultured for 72 h with varying concentrations
of SPC in the presence or absence of Con A (1 µg per ml). [3H]TdR
incorporation was assessed as described above.
Statistical analysis Student’s t test was used to determine the statistical
differences between means.
RESULTS
28–4 cells are more sensitive to TNFa than 24–2 cells The
sensitivity of cells to TNFα and IL-1 influences the effects of ceramides
on those cells, because ceramides are involved in the signaling pathway
of these synergizing cytokines. The 28–4 and 24–2 cells were cultured
for 48 h with TNFα and/or IL-1β in the presence of Con A at 1 µg
per ml. As shown in Fig 1, thymocytes, as a control, responded to
IL-1β and TNFα with strong synergism between these two cytokines
at concentrations of 10 u per ml or more of IL-1β and 500 u per ml
or more of TNFα, as reported previously (Ranges et al, 1988). In
24–2 cells, the addition of IL-1β augmented the proliferation, whereas
TNFα significantly enhanced the DNA synthesis only at a concentration
of 500 units per ml when IL-1β at 10 or 100 u per ml was simultaneously
added to the culture. In contrast, the proliferation of 28–4 was increased
by TNFα in a concentration-dependent manner, but not substantially
by IL-1β. Thus, 28–4 had higher sensitivity to TNFα and less
dependency on IL-1β than 24–2.
Augmentation of DNA synthesis of T cell clones by natural
ceramides in the presence of Con A The effects of natural
ceramides on the proliferation of 28–4 and 24–2 cells, along with those
of TNFα and IL-1β, were examined. As shown in Fig 2, in a 48 h
cultivation period, CIII and CIV at 0.2 µM failed to stimulate 28–4
and 24–2 cells in the absence of Con A. In a comparison between the
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Figure 1. Sensitivity of 28–4, 24–2, and thymocytes to TNFa and IL-1.
28–4, 24–2, and thymocytes were cultured for 48 h in the presence of varying
concentrations of IL-1β and TNFα. [3H]TdR was added to the culture 16 h
before harvest. Vertical bars represent SD.
BSA group without Con A and that with Con A, this lectin at 1 µg
per ml modestly augmented the proliferation in both types of cells.
This DNA synthesis enhanced by Con A was further elevated by the
addition of CIII or CIV in 28–4 and by CIV in 24–2 cells. The level
enhanced by CIII or CIV was higher than those of TNFα (2500 u
per ml) and IL-1β (10 u per ml) in 28–4 cells and comparable with
that enhanced by IL-1β in 24–2 cells. Concentrations of Con A at 0.2
and 5 µg per ml were too low to yield a response and too high to
make a difference in the responses, respectively (data not shown).
Therefore, 1 µg Con A per ml was optimal to detect the mitogenic
capacities of CIII and CIV for 24–2 and 28–4 cells.
The dose–response study showed that CIII and CIV enhanced DNA
synthesis of 28–4 and 24–2 cells optimally at concentrations of
0.05–0.5 µM in the presence of Con A (data not shown). Thus, we
employed these natural ceramides at a concentration of 0.5 µM in the
following experiments.
Figure 2. An appropriate concentration of Con A is required for
detection of the capacities of the natural ceramides to augment DNA
synthesis of 28–4 and 24–2 cells. 28–4 and 24–2 cells were cultured for 48 h
with CIII (0.2 µM), CIV (0.2 µM), IL-1β (10 u per ml), TNFα (2500 u per
ml), or BSA as a control, in the presence or absence of Con A (1 µg per ml).
[3H]TdR was added to the culture 16 h before harvest. *p , 0.05, compared
with the corresponding BSA group. Vertical bars represent SD.
Figure 3. Comparison between CIII, CIV, and C2 in the augmentative
effect of DNA synthesis of TNP-LNC, 28–4, and 24–2 cells. TNP-LNC
were cultured with or without trinitrophenylated Langerhans cell-enriched
epidermal cells (TNP-LC) for 68 h. 28–4 and 24–2 cells were cultured in the
presence of 1 µg per ml Con A for 48 h. CIII (0.5 µM), CIV (0.5 µM), and
C2 (1 µM) were added to cultures at the beginning of cultures. [3H]TdR was
added to the culture 16 h before harvest. The mean 6 SD of percentage
augmentation was obtained from three independent experiments. The
representative mean cpms of control (BSA) were as follows: nonstimulated
TNP-LNC, 2072; TNP-Langerhans cell-stimulated TNP-LNC, 90582; 28–4,
3055; and 24–2, 2865. Vertical bars represent SD.
Comparison between augmentative potentials for T cell prolif-
eration of natural and synthetic ceramides Figure 3 summarizes
the percentage augmentation of [3H]TdR incorporation by CIII, CIV,
and C2 in three types of cells. In TNP-LNC, CIII and CIV modestly
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promoted DNA synthesis at levels comparable with that of C2 when
cells were left unstimulated. The proliferation of LNC stimulated
antigenically with TNP-Langerhans cells was not enhanced by any
ceramide, suggesting that exogenous ceramides are incapable of further
stimulating fully activated T cells. On the other hand, in 28–4 cells
the degree of enhancement by the natural ceramide (250%–300%) was
higher than that by C2 (20%). CIV also augmented the proliferation
of 24–2 cells by 53%. These results suggested that these T cell clones
proliferated more vigorously in the presence of CIII and CIV than in
that of C2.
Figure 3, together with Fig 2, shows another important finding.
28–4 cells were more sensitive to natural ceramides than 24–2 cells in
terms of the proliferative responses. Because the sensitivity of 28–4
cells to TNFα is higher than that of 24–2 cells, TNFα sensitivity
seemed to be one of the factors that determine the responsiveness to
ceramides.
Modulatory action of natural ceramides for T cell proliferation
is influenced by activation levels of T cells and exposure time
to ceramides To further characterize dependency of action of
ceramides on cellular activation levels, we examined the effects of
natural ceramides on the proliferation of 28–4 and 24–2 cells stimulated
or not stimulated with TNFα. The 28–4 and 24–2 cells and thymocytes
were cultured for 20, 44, or 79 h in the presence or absence of CIII,
CIV, and/or TNFα, and the DNA synthesis was measured. In all
experiments, Con A was added at 1 µg per ml. In 20 h cultivation,
the [3H]TdR incorporation of the three types of cells was very low
and no significant effect was obtainable by the addition of natural
ceramide or TNFα (data not shown). When cultured for 44 h, TNFα-
sensitive 28–4 cells markedly proliferated in response to CIII and
CIV in the absence of TNFα, whereas TNFα alone enhanced the
proliferation (Fig 4A). This TNFα enhancement, however, was
significantly suppressed by the concomitant addition of CIII or CIV.
Thus, these natural ceramides exerted an augmentative effect when
the T cell clones were not activated by TNFα. In 24–2 cells, which
were less sensitive to TNFα, cultured for 44 h, CIV, but not CIII,
modestly enhanced the proliferation, and neither ceramide affected
the TNFα-induced proliferation (Fig 4B). In 79 h cultivation, the
proliferation of 28–4 cells was not enhanced by CIII or CIV and was
clearly reduced by TNFα (Fig 4D). In this culture period, CIII and
CIV did not affect DNA synthesis of 24–2 cells in the absence of
TNFα but markedly inhibited proliferation in its presence (Fig 4E).
In thymocytes, CIII inhibited the TNFα-enhanced proliferation of 44
h culture, and CIV had an inhibitory effect in both culture periods
(Fig 4C, F).
Taken together, these findings demonstrated that natural ceramides,
in particular CIV, enhanced DNA synthesis of TNFα-sensitive 28–4
cells in a culture period shorter than that of the usual 3 d T cell
proliferation assay. Inversely, cells activated by TNFα were suppressed
by the natural ceramides.
SPC augments the proliferation of resting splenocytes SPC,
instead of ceramides, is generated in atopic dermatitis because of
abnormal expression of sphingomyelin acylase (Murata et al, 1996).
Splenocytes, thymocytes, and TNP-LNC were cultured with SPC at
varying concentrations up to 10 µM in the presence or absence of
Con A at 1 µg per ml. As shown in Fig 5, splenocytes unstimulated
with Con A proliferated in response to SPC in a dose-dependent
manner. When cultured in the presence of Con A, however, splenocytes
exhibited only marginal proliferation at 2 µM of SPC. On the other
hand, neither thymocytes nor TNP-LNC responded to SPC at any
concentration when they were either stimulated or unstimulated with
Con A (data not shown). These results suggested that SPC has
mitogenic activity for resting lymphocytes.
DISCUSSION
Our previous study indicated that the exogenous addition of C2
augments DNA synthesis of resting splenocytes and immune LNC
(Tokura et al, 1996). By using natural ceramides, this study more clearly
demonstrated that exposure to ceramides differentially modulates T cell
Figure 4. Up- and down-modulatory effects of CIII and CIV on DNA
synthesis of 28–4, 24–2, and thymocytes, depending on exposure time
and TNFa-stimulated activation levels. 28–4, 24–2, and thymocytes were
cultured for 44 or 79 h with CIII, CIV, or BSA at 0.5 µM in the presence or
absence of TNFα (2500 u per ml). [3H]TdR was added to the culture 16 h
before harvest. *p , 0.05, compared with corresponding BSA group. Vertical
bars represent SD.
proliferation, depending on the sensitivity of T cells to TNFα, their
activation level, and the cultivation period with ceramides. Under
optimal conditions, the actions of CIII and CIV to induce the
proliferation of T cell clones were stronger than that of C2. Thus, not
only synthetic but also natural ceramides are capable of modulating
cellular kinetics of T cells, as has been reported in other types of cells
(Geilen et al, 1996; Hartfield et al, 1997).
Boucher et al (1995) have reported that acidic sphingomyelinase,
which yields ceramide by hydrolysis of sphingomyelin, enhances DNA
synthesis of splenocytes when added to culture concomitantly with an
anti-CD3 antibody. Our results showed that the exogenous ceramides
and Con A in our system functionally mimicked acidic sphingomyelin-
ase and the anti-CD3 antibody in the system of Boucher et al. To
activate T cells optimally, CD28 signaling synergizes with T cell
receptor (TCR)/CD3 stimulation (Rudd et al, 1994). CD28 cross-
linking activates the sphingomyelin pathway without any effect on
cellular diacylglycerol levels (Dressler et al, 1992; Yang et al, 1993),
whereas costimulation through the TCR complex and CD28 induces
an elevation of both cellular ceramide and diacylglycerol contents and
resultant T cell proliferation (Kolesnick and Fuks, 1995). Therefore,
the combination of ceramide and Con A appears to activate both
sphingomyelin and phosphatidylinositol pathways that are essential for
T cell proliferation. This concept is in accordance with the recent
finding that diacylglycerol protects cells from the apoptotic, lethal
effects of ceramide stimulation (Kolesnick et al, 1995).
The natural ceramides, in particular CIV, enhanced DNA synthesis
of TNFα-sensitive T cells in a culture period shorter than that of the
usual 3 d T cell proliferation assay; however, when cells were cultured
simultaneously with TNFα, their proliferation was suppressed by the
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Figure 5. Augmentation of splenocyte proliferation by SPC. Splenocytes
were cultured for 72 h with SPC at varying concentrations in the presence or
absence of Con A (1 µg per ml). [3H]TdR was added to the culture 16 h
before harvest. *p , 0.05, compared with the SPC-nonaddion group. Vertical
bars represent SD.
natural ceramides. It has been well demonstrated that ceramide mediates
the action of TNFα as a messenger (Kim et al, 1991; Dressler et al,
1992; Bettaieb et al, 1996) and TNFα is an agonist of sphingomyelin
turnover in various cells (Kim et al, 1991; Dressler et al, 1992; Mathias
et al, 1993). Therefore, the effect of ceramide is influenced by the
TNFα sensitivity of target cells. Although this study did not elaborate
the amounts of cellular ceramides in T cells cultured with ceramides
and/or TNFα, it appears that the combinatorial addition of TNFα
and ceramide or elongation of the culture period with ceramide leads
to excess contents of cellular ceramide, resulting in reduction in DNA
synthesis (Borchardt et al, 1994) or apoptosis of cells (Ji et al, 1995;
Geley et al, 1997). Ceramides have pleiotropic functions in cell
proliferation and differentiation depending on the cell type. C2 inhibits
the proliferation and induces the differentiation of leukemic cell line
HL-60 (Okazaki et al, 1989) and transformed keratinocytes (Wakita
et al, 1994), whereas cultured fibroblasts proliferate in response to C2
(Olivera et al, 1992). This study suggests that exposure to ceramides
exerts different effects on T cells, depending on the type and activation
level of the T cells. Controversial findings concerning the effects of
ceramides on T cell proliferation (Felding-Habermann et al, 1990;
Borchardt et al, 1994; Jolly et al, 1996) appear to be due to such
differences in the characteristics of the cells and culture conditions
used in each study.
It remains unclear from this study whether exogenous addition of
natural ceramides leads to an elevation of cellular ceramides and is
virtually the same as endogenous synthesis of ceramides. Nevertheless,
the capability of natural ceramides to modulate T cell proliferation
may provide an important insight into their involvement in some
inflammatory skin disorders. When stratum corneum is destroyed by
mechanical or inflammatory stimuli, it is plausible that ceramide
abundantly present in the cornified layer diffuses backwards and affects
skin-infiltrating T cells. In normal individuals aged 20–30 y, the total
ceramide content per mg of stratum corneum is 20–50 µg per mg
(Imokawa et al, 1991), equivalent to 0.04–0.1 µmol per mg. The active
concentration of natural ceramides in our study was 0.2 µmoles per
liter, equivalent to 0.04 µM per 200 ml. Therefore, provided that
1 mg of stratum corneum is dispersed in 200 ml of tissue fluid, the
resultant tissue concentration of ceramide would give rise to modulation
of T cells. In this case, ceramides might stimulate T cells, leading to
further exacerbation of the disorders. Alternatively, the increased
production of TNFα by keratinocytes in acutely and chronically
barrier-disrupted skin (Kupper, 1990; Wood et al, 1997) allows ceramide
to suppress the function of infiltrating T cells, resulting in downregul-
ation of exaggerated cutaneous reactions. This study also suggested
that SPC is mitogenic for resting T cells as well as keratinocytes
(Wakita et al, 1998). In atopic skin, where SPC is increased in amount
(Murata et al, 1996), SPC may exert an additional effect on T cells
upon barrier disruption.
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